HLA Typing for Transplant Market
HLA Typing for Transplant Market Size, Share & Trends Analysis Report By Type (Molecular Assays, and Non-Molecular Assays) By Product & Services (Reagents, Software, and Instruments) By Application (Diagnostics, and Research) By End-Users (Academic Institutes & Research Centers, Hospitals & Transplant Centers, and others) Forecast, 2026-2035
Industry Overview
HLA typing for transplant market was valued at $1,211.3 million in 2025 and is projected to reach $2,196.80 million by 2035, growing at a CAGR of 6.2% during the forecast period (2026-2035). The global HLA Typing for transplant market is expanding steadily as the demand for precise donor-recipient matching continues to rise. Advancements in molecular diagnostics and sequencing technologies are enhancing the accuracy and speed of HLA typing, making transplantation procedures safer and more effective. The increasing prevalence of organ failures and the corresponding growth in transplant procedures are further driving the need for reliable HLA testing. Healthcare providers and diagnostic laboratories are investing in high-resolution typing solutions to reduce post-transplant complications and improve patient outcomes. Additionally, supportive regulatory frameworks and rising awareness of transplantation benefits are contributing to market growth. As a result, both established and emerging markets are witnessing heightened adoption of HLA typing services.
Market Dynamics
Rising Adoption of Next-Generation Sequencing (NGS) in HLA Typing
The Global HLA Typing for Transplant Market is witnessing a significant shift toward next-generation sequencing technologies. NGS enables high-resolution and rapid identification of HLA alleles, improving transplant compatibility and patient outcomes. Increasing precision in donor-recipient matching is driving demand across hospitals, transplant centers, and diagnostic laboratories. The growing focus on personalized medicine further reinforces the adoption of NGS-based HLA typing solutions. Additionally, automation and bioinformatics advancements are reducing turnaround times, making NGS a preferred choice over traditional serological or PCR-based methods. This trend is expected to continue as healthcare providers seek reliable, efficient, and scalable HLA typing platforms.
Expansion of HLA Typing in Emerging Markets
Emerging markets are increasingly contributing to the growth of the HLA typing market, driven by rising awareness of organ transplantation and improving healthcare infrastructure. Countries in Asia-Pacific, Latin America, and the Middle East are witnessing higher adoption of HLA typing services, supported by government initiatives and investments in transplant programs. The expansion of diagnostic laboratories and collaboration with global biotech companies is enhancing accessibility and affordability. Growing prevalence of chronic diseases and related organ failures is further boosting the demand for transplantation, indirectly accelerating HLA typing adoption. As a result, emerging regions are expected to play a critical role in shaping the future growth trajectory of the global HLA typing for transplant market.
Market Segmentation
- Based on the type, the market is segmented into molecular assays and non-molecular assays.
- Based on the products & services, the market is segmented into reagents, software, and instruments.
- Based on the end-users, the market is segmented into academic institutes & research centers, hospitals & transplant centers, and others.
Molecular Assays Segment to Lead the Market with the Largest Share
The global HLA typing for transplant market is witnessing growth driven by the increasing use of molecular assays in transplantation procedures. These assays offer high accuracy in identifying HLA alleles, enabling precise donor-recipient compatibility assessments. The adoption of molecular techniques has reduced errors associated with traditional serological methods and improved overall transplant success rates. Laboratories and transplant centers are increasingly integrating advanced molecular platforms to streamline testing processes and enhance diagnostic reliability. The growing emphasis on personalized medicine and patient-specific treatment strategies is further promoting the uptake of molecular HLA typing.
Hospitals And Transplant: A Key Segment in Market Growth
The global HLA typing for transplant market is expanding as hospitals and transplant centers increasingly integrate HLA typing into their clinical workflows. These institutions are prioritizing accurate donor-recipient matching to enhance patient outcomes and reduce post-transplant complications. Rising numbers of organ transplant procedures have led healthcare facilities to invest in advanced HLA testing infrastructure and skilled personnel. Collaborative efforts between diagnostic laboratories and transplant centers are further strengthening the adoption of HLA typing services. The growing focus on precision medicine and individualized treatment protocols is driving consistent demand from medical institutions.
Regional Outlook
The global HLA typing for transplant market is further divided by geography, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
Increasing Demand For Organ And Stem Cell Transplants in the Europe
The Europe HLA typing for the transplant market is expanding as a result of increasing demand for organ and stem cell transplants across the region. Healthcare providers are emphasizing accurate HLA matching to minimize post-transplant complications and enhance patient survival rates. Technological advancements in molecular assays and automated typing systems are facilitating faster and more reliable testing. Government initiatives and healthcare programs promoting organ transplantation are driving wider adoption of HLA typing services. Moreover, collaborations between diagnostic centers and transplant facilities are enhancing accessibility to high-quality testing.
North America Region Dominates the Market with Major Share
The North America HLA Typing for Transplant Market is experiencing steady growth due to increasing organ transplant procedures and the adoption of advanced diagnostic technologies. Healthcare institutions are focusing on precise donor-recipient matching to reduce the risk of transplant rejection and improve patient outcomes. Rising investments in molecular diagnostics and high-resolution typing platforms are further supporting market expansion. Additionally, growing awareness of transplantation benefits and supportive reimbursement policies are encouraging the integration of HLA testing in clinical practice. Collaborative initiatives between hospitals, laboratories, and research organizations are accelerating the implementation of innovative HLA typing solutions. These factors collectively contribute to the sustained growth of the market in the region.
Market Players Outlook
The major companies operating in the global HLA typing for transplant market include Bio?Rad Laboratories, Inc., F. Hoffmann?La Roche Ltd. (Roche), Illumina, Inc., QIAGEN N.V., Thermo Fisher Scientific, Inc., among others. Market players are leveraging partnerships, collaborations, mergers and acquisitions strategies for business expansion and innovative product development to maintain their market positioning.
Recent Developments
- In February 2025, Roche introduced its proprietary, breakthrough sequencing by expansion (SBX) technology, establishing a new category of next-generation sequencing. SBX chemistry, combined with an innovative sensor module, offers ultra-rapid, high-throughput sequencing that is both flexible and scalable for a broad range of applications.
- In August 2024, QIAGEN announced the expansion of its Master Collaboration Agreement with AstraZeneca to develop and commercialize companion diagnostics (CDx) for AstraZeneca’s future therapies being developed to address chronic diseases. Under the agreement, QIAGEN will develop and validate a genotyping assay using QIAGEN’s syndromic testing platform QIAstat-Dx.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global HLA typing for transplant market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Global HLA Typing For Transplant Market Sales Analysis – Technology | Product & Services | Application | End-User | ($ Million)
- HLA Typing For Transplant Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key HLA Typing For Transplant Market Trends
- Market Recommendations
- Porter's Five Forces Analysis for the HLA Typing For Transplant Market
- Competitive Rivalry
- Threat of New Entrants
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Market Determinants
- Market Drivers
- Drivers For Global HLA Typing For Transplant Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Global HLA Typing For Transplant Market: Impact Analysis
- Market Opportunities
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – HLA Typing For Transplant Market Revenue and Share by Manufacturers
- HLA Typing For Transplant Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Bio?Rad Laboratories, Inc.
- Overview
- Product Portfolio
- Financial Analysis (Subject to Data Availability)
- SWOT Analysis
- Business Strategy
- Hoffmann?La Roche Ltd. (Roche)
- Overview
- Product Portfolio
- Financial Analysis (Subject to Data Availability)
- SWOT Analysis
- Business Strategy
- Illumina, Inc.
- Overview
- Product Portfolio
- Financial Analysis (Subject to Data Availability)
- SWOT Analysis
- Business Strategy
- QIAGEN N.V.
- Overview
- Product Portfolio
- Financial Analysis (Subject to Data Availability)
- SWOT Analysis
- Business Strategy
- Thermo Fisher Scientific, Inc.
- Overview
- Product Portfolio
- Financial Analysis (Subject to Data Availability)
- SWOT Analysis
- Business Strategy
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- Bio?Rad Laboratories, Inc.
- Key Company Analysis
- Global HLA Typing For Transplant Market Sales Analysis by Technology ($ Million)
- Non-Molecular Assays
- Serological Assays
- Mixed Lymphocyte Culture Assays
- Molecular Assays
- PCR-Based Molecular Assay
- Sequence-Specific Primer (SSP-PCR)
- Sequence-Specific Oligonucleotide (SSO-PCR)
- Sequence-Based Typing (SBT-PCR)
- Others
- Sequencing-Based Molecular Assays
- Sanger Sequencing
- Next-Generation Sequencing
- PCR-Based Molecular Assay
- Non-Molecular Assays
- Global HLA Typing For Transplant Market Sales Analysis by Product & Services ($ Million)
- Reagents
- Software
- Instruments
- Global HLA Typing For Transplant Market Sales Analysis by Application ($ Million)
- Diagnostics
- Research
- Global HLA Typing For Transplant Market Sales Analysis by End-User ($ Million)
- Academic Institutes & Research Centers
- Hospitals & Transplant Centers
- Donor Registries
- Regional Analysis
- North American HLA Typing For Transplant Market Sales Analysis – Technology | Product & Services | Application | End-User | Country ($ Million)
- Macroeconomic Factors for North America
- United States
- Canada
- European HLA Typing For Transplant Market Sales Analysis – Technology | Product & Services | Application | End-User | Country ($ Million)
- Macroeconomic Factors for Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia-Pacific HLA Typing For Transplant Market Sales Analysis – Technology | Product & Services | Application | End-User | Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- Rest of Asia-Pacific
- Rest of the World HLA Typing For Transplant Market Sales Analysis – Technology | Product & Services | Application | End-User | Country ($ Million)
- Macroeconomic Factors for Rest of the World
- Latin America
- Middle East and Africa
- Company Profiles
- BAG Diagnostics GmbH
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Becton, Dickinson and Company (BD)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Biofortuna Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Bio?Rad Laboratories, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- CareDx, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Creative Biolabs LLC
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Eurobio Scientific
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Hoffmann?La Roche Ltd. (Roche)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Fujirebio
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- GenDx BV (Genome Diagnostics B.V.)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- HistoGenetics LLC
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Illumina, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Immucor, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Luminex Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Omixon Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Pacific Biosciences of California, Inc. (PacBio)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- QIAGEN N.V.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Takara Bio Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- TBG Biotechnology Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Thermo Fisher Scientific, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- BAG Diagnostics GmbH
1. Global HLA Typing For Transplant Market Research and Analysis by Technology, 2025–2035 ($ Million)
2. Global Non-Molecular Assays HLA Typing For Transplant Market Research and Analysis by Region, 2025–2035 ($ Million)
3. Global Molecular Assays HLA Typing For Transplant Market Research and Analysis by Region, 2025–2035 ($ Million)
4. Global HLA Typing For Transplant Market Research and Analysis by Product & Services, 2025–2035 ($ Million)
5. Global Reagents HLA Typing For Transplant Market Research and Analysis by Region, 2025–2035 ($ Million)
6. Global Software HLA Typing For Transplant Market Research and Analysis by Region, 2025–2035 ($ Million)
7. Global Instruments HLA Typing For Transplant Market Research and Analysis by Region, 2025–2035 ($ Million)
8. Global HLA Typing For Transplant Market Research and Analysis by Applications, 2025–2035 ($ Million)
9. Global Diagnostics Application HLA Typing For Transplant Market Research and Analysis by Region, 2025–2035 ($ Million)
10. Global Research Application HLA Typing For Transplant Market Research and Analysis by Region, 2025–2035 ($ Million)
11. Global HLA Typing For Transplant Market Research and Analysis by End-Users, 2025–2035 ($ Million)
12. Global HLA Typing Transplant For Academic Institutes & Research Centers Market Research and Analysis by Region, 2025–2035 ($ Million)
13. Global HLA Typing Transplant For Hospitals & Transplant Centers Market Research and Analysis by Region, 2025–2035 ($ Million)
14. Global HLA Typing Transplant For Donor Registries Market Research and Analysis by Region, 2025–2035 ($ Million)
15. Global HLA Typing For Transplant Market Research and Analysis by Region, 2025–2035 ($ Million)
16. North American HLA Typing For Transplant Market Research and Analysis by Country, 2025–2035 ($ Million)
17. North American HLA Typing For Transplant Market Research and Analysis by Technology, 2025–2035 ($ Million)
18. North American HLA Typing For Transplant Market Research and Analysis by Product & Services, 2025–2035 ($ Million)
19. North American HLA Typing For Transplant Market Research and Analysis by Application, 2025–2035 ($ Million)
20. North American HLA Typing For Transplant Market Research and Analysis by End-User, 2025–2035 ($ Million)
21. European HLA Typing For Transplant Market Research and Analysis by Country, 2025–2035 ($ Million)
22. European HLA Typing For Transplant Market Research and Analysis by Technology, 2025–2035 ($ Million)
23. European HLA Typing For Transplant Market Research and Analysis by Product & Services, 2025–2035 ($ Million)
24. European HLA Typing For Transplant Market Research and Analysis by Application, 2025–2035 ($ Million)
25. European HLA Typing For Transplant Market Research and Analysis by End-User, 2025–2035 ($ Million)
26. Asia-Pacific HLA Typing For Transplant Market Research and Analysis by Country, 2025–2035 ($ Million)
27. Asia-Pacific HLA Typing For Transplant Market Research and Analysis by Technology, 2025–2035 ($ Million)
28. Asia-Pacific HLA Typing For Transplant Market Research and Analysis by Product & Services, 2025–2035 ($ Million)
29. Asia-Pacific HLA Typing For Transplant Market Research and Analysis by Application, 2025–2035 ($ Million)
30. Asia-Pacific HLA Typing For Transplant Market Research and Analysis by End-User, 2025–2035 ($ Million)
31. Rest of the World HLA Typing For Transplant Market Research and Analysis by Region, 2025–2035 ($ Million)
32. Rest of the World HLA Typing For Transplant Market Research and Analysis by Technology, 2025–2035 ($ Million)
33. Rest of the World HLA Typing For Transplant Market Research and Analysis by Product & Services, 2025–2035 ($ Million)
34. Rest of the World HLA Typing For Transplant Market Research and Analysis by Application, 2025–2035 ($ Million)
35. Rest of the World HLA Typing For Transplant Market Research and Analysis by End-User, 2025–2035 ($ Million)
1. Global HLA Typing For Transplant Market Share by Technology, 2025 Vs 2035 (%)
2. Global Non-Molecular Assays HLA Typing For Transplant Market Share by Region, 2025 Vs 2035 (%)
3. Global Molecular Assays HLA Typing For Transplant Market Share by Region, 2025 Vs 2035 (%)
4. Global HLA Typing For Transplant Market Share by Product & Services, 2025 Vs 2035 (%)
5. Global Reagents HLA Typing For Transplant Market Share by Region, 2025 Vs 2035 (%)
6. Global Software HLA Typing For Transplant Market Share by Region, 2025 Vs 2035 (%)
7. Global Instruments HLA Typing For Transplant Market Share by Region, 2025 Vs 2035 (%)
8. Global HLA Typing for Transplant Market Share by Applications, 2025 Vs 2035 (%)
9. Global Diagnostics Application HLA Typing For Transplant Market Share by Region, 2025 Vs 2035 (%)
10. Global Research Application HLA Typing for Transplant Market Share by Region, 2025 Vs 2035 (%)
11. Global HLA Typing for Transplant Market Share by End-Users, 2025 Vs 2035 (%)
12. Global HLA Typing Transplant For Academic Institutes & Research Centers Market Share by Region, 2025 Vs 2035 (%)
13. Global HLA Typing Transplant For Hospitals & Transplant Centers Market Share by Region, 2025 Vs 2035 (%)
14. Global HLA Typing Transplant For Donor Registries Market Share by Region, 2025 Vs 2035 (%)
15. Global HLA Typing For Transplant Market Research and Analysis by Region, 2025–2035 ($ Million)
16. US HLA Typing For Transplant Market Size, 2025–2035 ($ Million)
17. Canada HLA Typing For Transplant Market Size, 2025–2035 ($ Million)
18. UK HLA Typing For Transplant Market Size, 2025–2035 ($ Million)
19. France HLA Typing For Transplant Market Size, 2025–2035 ($ Million)
20. Germany HLA Typing For Transplant Market Size, 2025–2035 ($ Million)
21. Italy HLA Typing For Transplant Market Size, 2025–2035 ($ Million)
22. Spain HLA Typing For Transplant Market Size, 2025–2035 ($ Million)
23. Russia HLA Typing For Transplant Market Size, 2025–2035 ($ Million)
24. Rest of Europe HLA Typing For Transplant Market Size, 2025–2035 ($ Million)
25. India HLA Typing For Transplant Market Size, 2025–2035 ($ Million)
26. China HLA Typing For Transplant Market Size, 2025–2035 ($ Million)
27. Japan HLA Typing For Transplant Market Size, 2025–2035 ($ Million)
28. South Korea HLA Typing For Transplant Market Size, 2025–2035 ($ Million)
29. Australia and New Zealand HLA Typing For Transplant Market Size, 2025–2035 ($ Million)
30. ASEAN Economies HLA Typing For Transplant Market Size, 2025–2035 ($ Million)
31. Rest of Asia-Pacific HLA Typing For Transplant Market Size, 2025–2035 ($ Million)
32. Latin America HLA Typing For Transplant Market Size, 2025–2035 ($ Million)
33. Middle East and Africa HLA Typing For Transplant Market Size, 2025–2035 ($ Million)
- Printable version
- No restriction to number of user within the company
Contact Sales
FAQS
The size of the HLA Typing for Transplant Market in 2025 is estimated to be around $1,211.3 million.
North America holds the largest share in the HLA Typing for Transplant Market.
Leading players in the HLA Typing for Transplant Market include Bio Rad Laboratories, Inc., F. Hoffmann La Roche Ltd. (Roche), Illumina, Inc., QIAGEN N.V., Thermo Fisher Scientific, Inc., among others.
HLA Typing for Transplant Market is expected to grow at a CAGR of 6.2% from 2026 to 2035.
HLA Typing for Transplant market growth is driven by increasing organ transplant procedures, rising prevalence of genetic disorders, and advancements in molecular diagnostic technologies.
